Results 251 to 260 of about 840,804 (341)

Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients

Hepatology, 2012
P. Bedossa, C. Poitou, N. Veyrie, J. Bouillot, A. Basdevant, V. Paradis, J. Tordjman, K. Clément   +7 more
semanticscholar   +1 more source

Urinary markers in heart failure – types, timing and thresholds. European Journal of Heart Failure expert consensus document

European Journal of Heart Failure, EarlyView.
Pathophysiologic mechanisms of heart failure (HF) (i.e. renin–angiotensin–aldosterone system [RAAS], congestion, and inflammation), together with patient‐related factors such as diabetes, hypertension, and chronic kidney disease (CKD), contribute to kidney function decline and glomerular or tubular injury.
Masatake Kobayashi, Biykem Bozkurt, Peder Langeland Myhre, Juan Carlos Lopez Azor, Mateusz Guzik, Gracjan Iwanek, Guillaume Baudry, Marta Cobo‐Marcos, Òscar Miró, Jeroen Dauw, Piotr Ponikowski, Wilfried Mullens, Alberto Palazzuoli, Marco Metra, Jan Biegus   +14 more
wiley   +1 more source

Sleep Quality of Morbidly Obese Patients After Bariatric Surgery. [PDF]

J Metab Bariatr Surg
Kim Y, Yang AR, Koh K, Seo KW, Kim KH.
europepmc   +1 more source

Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss.

Diabetes, 2005
R. Cancello, C. Henegar, N. Viguerie, S. Taleb, C. Poitou, C. Rouault, M. Coupaye, V. Pelloux, D. Hugol, J. Bouillot, A. Bouloumié, G. Barbatelli, S. Cinti, P. Svensson, G. Barsh, Jean-Daniel Zucker, A. Basdevant, D. Langin, K. Clément   +18 more
semanticscholar   +1 more source

Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT)

Environmental and Molecular Mutagenesis, EarlyView.
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons, Marc A. Beal, Kerry L. Dearfield, George R. Douglas, Min Gi, B. Bhaskar Gollapudi, Robert H. Heflich, Katsuyoshi Horibata, Michelle Kenyon, Alexandra S. Long, David P. Lovell, Anthony M. Lynch, Meagan B. Myers, Stefan Pfuhler, Alisa Vespa, Andreas Zeller, George E. Johnson, Paul A. White   +17 more
wiley   +1 more source

Risk factors for extubation-related complications in morbidly obese patients undergoing bariatric surgery: a retrospective cohort study. [PDF]

J Anesth
Saracoglu A, Vegesna ARR, Abdallah BM, Idrous AMOA, Elshoeibi AM, Varghese CN, Elhassan OO, Shakeel A, Karam M, Rizwan M, Bashah MM, Saracoglu KT.   +11 more
europepmc   +1 more source

Dynamics of daily monitoring of blood pressure in patients with morbid obesity after bariatric treatment

, 2017
Т.В. Колесник, Ya.S. Bereznitsky, Р.В. Дука, Р.В. Дука, Э Л Колесник, Э Л Колесник, Г.А. Косова, A. V. Nadyuk   +7 more
openalex   +2 more sources

Cardiovascular morbidity following epilepsy: A nationwide retrospective cohort study in South Korea

Epilepsia Open, EarlyView.
Abstract Objective This study evaluated the long‐term risk of major cardiovascular diseases (CVDs) in patients with epilepsy using a nationwide cohort, aiming to address critical gaps in population‐based evidence on brain–heart interactions. Methods Data from the Korean National Health Insurance Service (2002–2013) were analyzed.
Youngoh Bae, Chaeyoon Kang, Yejin Lee, Haerim Cho, Hohyun Jung, Seung Won Lee   +5 more
wiley   +1 more source

Genomic Exploration of Nonalcoholic Fatty Liver Disease: Insights From Gene Expression and Variation in Morbidly Obese Individuals. [PDF]

J Obes
Rafaa TA, Khudhair SA, Mohammed ZY, Suleiman AA.   +3 more
europepmc   +1 more source

SURGICAL TREATMENT OF MORBID OBESITY

, 2013
V. A. Yudin, И А Усачев, А. А. Melnikov   +2 more
openalex   +2 more sources